These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5875508)

  • 1. [A new phenothiazine drug in the therapy of kinetosic disorders caused by air-sickness].
    Caporale R; Curi L
    Valsalva; 1965; 41():Suppl 1:52-62. PubMed ID: 5875508
    [No Abstract]   [Full Text] [Related]  

  • 2. Theory of antimotion sickness drug mechanisms.
    Wood CD; Graybiel A
    Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
    [No Abstract]   [Full Text] [Related]  

  • 3. The antimotion sickness drugs.
    Wood CD; Graybiel A
    Otolaryngol Clin North Am; 1973 Feb; 6(1):301-13. PubMed ID: 4220285
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimotion sickness drug efficacy.
    Wood CD; Cramer DB; Graybiel A
    Otolaryngol Head Neck Surg; 1981; 89(6):1041-4. PubMed ID: 6121316
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-emetics.
    Cockel R
    Practitioner; 1971 Jan; 206(231):56-63. PubMed ID: 5540195
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic control of vomiting.
    Davis LE
    J Am Vet Med Assoc; 1980 Feb; 176(3):241-2. PubMed ID: 7364635
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacodynamics of drugs used to control motion sickness. Experimental methods and new synthesis in the phenothiazine group: (Beta-dimethylaminoethyl)-aminoacetyl-10-phenothiazine or 462].
    FROMMEL E
    Arzneimittelforschung; 1963 Jul; 13():573-81. PubMed ID: 13945798
    [No Abstract]   [Full Text] [Related]  

  • 8. The laboratory assessment of anti-motion sickness and anti-vertigo drugs.
    Barber HO; Basser W; Johnson WH; Takahashi P
    Can Med Assoc J; 1967 Dec; 97(24):1460-5. PubMed ID: 4863013
    [No Abstract]   [Full Text] [Related]  

  • 9. New therapy of motion sickness.
    Stebbins PL
    Aerosp Med; 1966 Feb; 37(2):186. PubMed ID: 5906040
    [No Abstract]   [Full Text] [Related]  

  • 10. Motion sickness.
    Noel P; Norris C
    J La State Med Soc; 1996 Jan; 148(1):7-11. PubMed ID: 8576633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of No-Shpa in combination with vitamins in motion sickness].
    Usachev VV; Sabaev VV; Matveev AD; Popov AG
    Kosm Biol Aviakosm Med; 1981; 15(3):82-3. PubMed ID: 7289553
    [No Abstract]   [Full Text] [Related]  

  • 12. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What you thought you knew about motion sickness isn't necessarily so.
    Cowings PS; Malmstrom FV
    Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motion sickness is linked to nystagmus-related trigeminal brain stem input: a new hypothesis.
    Gupta VK
    Med Hypotheses; 2005; 64(6):1177-81. PubMed ID: 15823712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of perphenazine and systral against motion sickness.
    MILCH LJ; FRANKL HD; RENZI AA
    J Appl Physiol; 1959 Mar; 14(2):245-6. PubMed ID: 13641152
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection of an antimotion sickness drug.
    Wood CD
    J La State Med Soc; 1970 Apr; 122(4):95-8. PubMed ID: 4913510
    [No Abstract]   [Full Text] [Related]  

  • 17. Motion sickness susceptibility.
    Golding JF
    Auton Neurosci; 2006 Oct; 129(1-2):67-76. PubMed ID: 16931173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in the therapy of motion sickness: the dimenhydrinate-containing chewing gum dragee].
    Reimann HJ; Erbel F; Bergemann B
    Ther Ggw; 1981 Dec; 120(12):1171-80. PubMed ID: 7330785
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlorpheniramine for motion sickness.
    Buckey JC; Alvarenga D; Cole B; Rigas JR
    J Vestib Res; 2004; 14(1):53-61. PubMed ID: 15156097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.